Cancer And Blood Disorder Drugs Lead EU Novel Drug Approvals In 2024
Cancer retained its crown as 37 novel drugs were approved for pan-EU marketing last year; treatments for blood disorders followed closely behind in what was another slow year at the European Medicines Agency.